🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial is to determine the pharmacokinetic and...
Status
Completed
Location
Lotus Clinical Research, Inc.
Start Date
2016-01
Trial ID
NCT02641340
Treatments Being Tested
This study will explore effectiveness of three doses of fentanyl sublingual...
Status
Withdrawn
Location
Maricopa Medical Center
Start Date
TBD
Trial ID
NCT02137525
The purpose of this study was to assess the 90-day safety of fentanyl subli...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00538863
Treatments Being Tested
A phase II, prospective, multicentre, single-blinded, randomised study (whe...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-02-01
Trial ID
NCT03809455
Treatments Being Tested
This is a phase III, randomized, double-blind, placebo-controlled, multicen...
Status
Completed
Location
InSys Therapeutics, Incorporated
Start Date
2007-10
Trial ID
NCT00538850
Treatments Being Tested
The primary objective of this study is to determine the pharmacokinetic and...
Status
Completed
Location
Lotus Clinical Research
Start Date
2015-10
Trial ID
NCT02576353
Treatments Being Tested
The objective of this study was to compare the rate of absorption and bioav...
Status
Completed
Location
CEDRA Clinical Research, LLC
Start Date
2007-04
Trial ID
NCT01780233
The goal of this clinical research study is to learn if fentanyl can help s...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2016-01-04
Trial ID
NCT02597478
Treatments Being Tested
The purpose of this study is to examine the efficacy and safety of sublingu...
Status
Terminated
Location
Loyola University Medical Center Burn Unit
Start Date
2013-09
Trial ID
NCT02241486
Treatments Being Tested
A partially randomized, open-label, 3-way crossover, single-center, systemi...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02470390
Treatments Being Tested